There is evidence to suggest that the symptoms of a severe shock seen in fatal gas gangrene in man caused by Cl. welchii type A cannot be attributed entirely to poisoning by Cl. welchii alpha toxin.
tJ~7 OCT 1970 Animal Experiments and the Etiology of Gas Gangrene There is evidence to suggest that the symptoms of a severe shock seen in fatal gas gangrene in man caused by Cl. welchii type A cannot be attributed entirely to poisoning by Cl. welchii alpha toxin. To investigate this problem animal experiments are essential. It has been found that fatal infections with Cl. welchii type A can be produced in guinea-pigs passively immunized with very large amounts of alpha antitoxin. In these circumstances it is highly unlikely that alpha toxin plays any part in the production of shock. A possible explanation is the remarkable ability of Cl. welchii to remove oxygen from its environment with a correspondingly rapid fall in the oxidationreduction potential (Eh) of the tissue. We have evidence to suggest that the severe local anoxia produced by this organism can cause a rapid increase in vascular permeability which leads to severe hvmoconcentration and shock.
It seems quite possible that a phenomenon of this kind could account for the failure of antitoxin to prevent fatal shock in severe cases of gas gangrene in man.
Dr F T Perkins (National Institutefor Medical Research, Holly Hill, London NW3)
The Use of Standardized Cell Substrates as an Alternative to Primary Animal Tissue for Vaccine Production When we look at the enormous developments that have taken place in virus vaccine production it is surprising that so little attention has been given to the standardization of the cell substrate. There is a wealth of information on the growth requirements of different cell cultures and much has been done to obtain reproducibility between batches of calf serum. The virus used for vaccine production is selected with the utmost caution requiring carefully controlled clinical trials to ensure that it is both safe and immunogenic. Indeed the virus seed pool used as the starting point for the production of each batch of vaccine is thoroughly checked to ensure its freedom from extraneous agents and untoward characteristics. Finally, each batch of vaccine undergoes the most stringent tests to ensure its safety. It seems logical to suggest that just as much care and attention should be given to the selection, testing and standardization of the cell substrate used for the propagation of the virus to be incorporated in the vaccine.
What are the alternatives to primary monkey kidney tissue? Several have been suggested: Earle's mouse L cells, continuous monkey kidney cells and even chick embryo fibroblast cell lines. In making a choice several conditions must be satisfied: (1) The cell must remain normal throughout life. (2) It should be embryonic tissue since these are the least likely to be inherently contaminated.
(3) It should be tissue from a nondifferentiating organ. (4) It must be a tissue undergoing a sufficient number of cell doublings to provide an economic source of tissue to the manufacturer. (5) It should be a tissue susceptible to most human viruses. Such a cell line was started by Professor L Hayflick and Dr P Moorhead when they established a population of human embryo lung fibroblast cells. One such cell line is known as WI-38. Many laboratories have examined this tissue and none has found a contaminating virus, whereas all have found the cells to remain normal throughout 30 to 35 cell doublings. We have learnt a great deal about the practical limits of handling such cells so that we are now in a position to propose recommendations to those wishing to establish their own cell line.
In general the criteria are concerned with obtaining uncontaminated tissue from a normal person, proving its normality throughout its finite life and showing that extraneous agents or untoward reactions are not likely to occur in use. Many of the tests may seem somewhat tedious but there are no tests proposed for a new cell substrate that have not been satisfied already by the WI-38 cell line.
Even though the use of a standardized cell substrate may reduce the number of monkeys killed in order to produce monkey kidney cell cultures, the reduction in total number of monkeys required for medical research will be insignificant. The majority are used for the testing of vaccines and nothing can replace the need for animal tests in this respect.
The President: Is there, in this system, an opportunity for producing vaccines which so far we have not been able to produce? Dr F T Perkins: I think that one of the biggest developments will be in rabies vaccine. Rabies so far has had to be produced in the brains of animals, since the virus will grow only in that site. Using brain tissue for inoculation of humans is highly dangerous. The only development which has been made is to use suckling animals before the dangerous component of the brain develops. But there are some very exciting developments in the production of a rabies vaccine in these human diploid cells. The experimental vaccines have now been shown in monkeys and in dogs to protect the animals against street virus. I think it is particularly pertinent for us to mention this having in mind the accident which recently occurred in this country; we cannot lose sight of the desirability of having an effective and safe rabies vaccine in the United Kingdom.
Mr W J Perkins (National Institute for Medical Research, Mill Hill, London NW7)
Application of Computers in Association with Animal Experiments
In many cases of animal experiments in medical research, animals are used as models of human behaviour. They satisfy two criteria for modelling in that they resemble the ultimate system being studied and biomedical research workers are familiar with animal systems. In the final application to human systems, as with the long-term sideeffects of drugs, some human experiments may be necessary. The pattern is to study lower order systems for the initial experiments and the question is whether we really start low enough. Simple systems may be described mathematically with the equations implemented on a computer, to simulate their behaviour. Assuming for the moment that simulation is a valuable method, and I hope the moon landings have indicated this, biomedical workers will need to familiarize themselves with the appropriate mathematical techniques if they are to use computers as lower order models. As computers can deal with the solution of equations, the research worker has the less difficult task of formulating his ideas into equations. These models may be used at the early stage of an initial hypothesis to test ideas and act as a guide to those animal experiments most likely to provide useful information.
Once a model has been validated for a particular usage, it may also provide an alternative to difficult internal measurement by calculation from simple external measurement.
Results from experimental data often need to be processed and analysed before any conclusions may be drawn and it is at this stage that defects in the experimental procedures might be found. Where a computer can be used on-line to an experiment, the processed output may be obsetved immediately and appropriate action taken on the one experiment.
Comparing any two variables of n parameters could involve a number of experiments upon different animals. Here the experimental procedures are elaborated in order to simplify the analysis. An alternative could be to measure all n variables in the one experiment, producing simple and probably more effective dynamic measurements but necessitating a far more complex procedure for the analysis. However, there are sophisticated mathematical techniques that may be used in association with computers to provide information from data.
Computers may be used before, during and after animal experiments and could possibly help in reducing the number of animals used.
Professor G M Wilson
(University Department ofMedicine, Western Infirmary, Glasgow WI)
The Experimental Trial of New Drugs in Man As a medical student in 1939 I was taught that the correct and most effective method of treating acute anuric renal failure was the intravenous infusion of sodium sulphate in normal saline (Dunlop et al. 1939) . The certainty of this statement was emphasized by quoting the strength of
